Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA7 | P43166 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL28937184 | 0.95 | TSHR (0.41) | TSHRL3MBTL1KMT2AMEN1NPC1 | |
| SCHEMBL2829961 | 0.89 | KMT2A (0.42) | TSHRKMT2AMAPTLMNAALDH1A1 | |
| SCHEMBL2832574 | 0.88 | ALDH1A1 (0.47) | TSHRL3MBTL1KMT2AMAPTLMNA | |
| SCHEMBL27501121 | 0.86 | TSHR (0.41) | TSHRL3MBTL1KMT2AMEN1NPC1 | |
| SCHEMBL28785157 | 0.86 | GAA (0.37) | TSHRL3MBTL1KMT2AMEN1NPC1 | |
| SCHEMBL2834707 | 0.86 | KMT2A (0.51) | TSHRL3MBTL1KMT2AMEN1TP53 | |
| SCHEMBL2831392 | 0.86 | KMT2A (0.47) | TSHRL3MBTL1KMT2AMEN1LMNA | |
| SCHEMBL2001481 | 0.84 | TSHR (0.52) | TSHRL3MBTL1KMT2ACA12CA1 | |
| SCHEMBL2838554 | 0.84 | NPC1 (0.36) | TSHRL3MBTL1KMT2AMEN1NPC1 | |
| SCHEMBL27836209 | 0.84 | TSHR (0.46) | TSHRL3MBTL1KMT2AMEN1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111855848-B | Method for analyzing genotoxic impurities in moxifloxacin hydrochloride starting material | 山东省食品药品检验研究院 | 2022-02-18 | — | — | CN | claimed |
| CN-111855848-A | Method for analyzing genotoxic impurities in moxifloxacin hydrochloride starting material | 山东省食品药品检验研究院 | 2020-10-30 | — | — | CN | claimed |
| CN-111855848-B | Method for analyzing genotoxic impurities in moxifloxacin hydrochloride starting material | 山东省食品药品检验研究院 | 2022-02-18 | — | — | CN | disclosed |
| CN-111855848-B | Method for analyzing genotoxic impurities in moxifloxacin hydrochloride starting material | 山东省食品药品检验研究院 | 2022-02-18 | — | — | CN | disclosed |
| CN-111855848-A | Method for analyzing genotoxic impurities in moxifloxacin hydrochloride starting material | 山东省食品药品检验研究院 | 2020-10-30 | — | — | CN | disclosed |
| CN-111855848-A | Method for analyzing genotoxic impurities in moxifloxacin hydrochloride starting material | 山东省食品药品检验研究院 | 2020-10-30 | — | — | CN | disclosed |
| US-10385065-B2 | Antibacterial compounds | REDX PHARMA PLC (GB) | 2019-08-20 | — | — | US | disclosed |
| US-10385065-B2 | Antibacterial compounds | REDX PHARMA PLC (GB) | 2019-08-20 | — | — | US | disclosed |
| US-20170158708-A1 | ANTIBACTERIAL COMPOUNDS | REDX PHARMA PLC (GB) | 2017-06-08 | — | — | US | disclosed |
| US-20170158708-A1 | ANTIBACTERIAL COMPOUNDS | REDX PHARMA PLC (GB) | 2017-06-08 | — | — | US | disclosed |
| US-20170158708-A1 | ANTIBACTERIAL COMPOUNDS | REDX PHARMA PLC (GB) | 2017-06-08 | — | — | US | disclosed |
| US-7094780-B1 | 3-aminoquinazolin-2,4-dione antibacterial agents | WARNER LAMBERT COMPANY LLC (US) | 2006-08-22 | — | — | US | disclosed |
| US-20060183762-A1 | 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS | ZOETIS WLC LLC | 2006-08-17 | — | — | US | disclosed |
| US-20050143407-A1 | Process for porducing quinolonecarboxylic acid derivative | DAIICHI PHARMACEUTICAL CO., LTD (JP) | 2005-06-30 | — | — | US | disclosed |
| EP-1518856-A1 | PROCESS FOR PRODUCING QUINOLONECARBOXYLIC ACID DERIVATIVE | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2005-03-30 | — | — | EP | disclosed |
| EP-1255739-A1 | 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS | WARNER-LAMBERT COMPANY (US) | 2002-11-13 | — | — | EP | disclosed |
| US-20020049223-A1 | Quinoline and naphthyridine carboxylic acid antibacterials | ABBOTT LABORATORIES | 2002-04-25 | — | — | US | disclosed |
| CN-1070191-C | Novel quinolone-or naphthalenone-carboxylic acid derivatives or salts thereof | TOYAMA CHEMICAL CO LTD (JP) | 2001-08-29 | — | — | CN | disclosed |
| WO-2001053273-A1 | 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS | WARNER-LAMBERT COMPANY (US) | 2001-07-26 | — | — | WO | disclosed |
| CN-1158611-A | Novel quinolone-or naphthyridonecarboxylic acid derivative or salt thereof | TOYAMA CHEMICAL CO LTD (JP) | 1997-09-03 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170158708-A1 | ANTIBACTERIAL COMPOUNDS | ABCC1, SLC11A2, NQO2 | TSHR 4571/4885L3MBTL1 2582/4885KMT2A 4283/4885 |
| US-20060183762-A1 | 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS | ABL1, NQO2, CBR3 | TSHR 1500/4885L3MBTL1 3671/4885KMT2A 1288/4885 |
| US-20050143407-A1 | Process for porducing quinolonecarboxylic acid derivative | PORCN, POR, COASY | TSHR 4756/4885L3MBTL1 4869/4885KMT2A 4350/4885 |
| US-20020049223-A1 | Quinoline and naphthyridine carboxylic acid antibacterials | NQO2, NQO1, NDUFA7 | TSHR 3942/4885L3MBTL1 3816/4885KMT2A 3343/4885 |
| US-10385065-B2 | Antibacterial compounds | ABCC1, SLC11A2, NQO2 | TSHR 4571/4885L3MBTL1 2582/4885KMT2A 4283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.